TB-500
Name used for thymosin-beta-4-related products. Fragment and full-length protein must be distinguished.
Search names: TB 500
Evidence
Catalogue entry · see sources
Describes the linked sources, not an overall score for product quality or effectiveness.Half-life
Vital: ~2 h
Transcribed from the recorded catalogue; experimental conditions are not always specified in the value field.Statistics reference: 2 hours
Estimate / borrowed valueContext and sources for the statistics reference
Borrowed from full-length thymosin beta-4 given intravenously; neither the fragment nor subcutaneous TB-500 was measured.
2 hours · Catalogue information from PeptideTracker.ai; read the limitation above. PeptideTracker.ai · TB-500 ↗
Half-life, duration of effect and shelf life are different measures. Catalogue values may differ between variants and administration routes. Curves continue to use their stated statistics reference.
Adverse effects and limitations
The regulatory source below describes safety concerns or data gaps. Administration route and product identity matter.
Sources and further reading
Vital · user-supplied screen recordings, 1 Nov 2026
Regulatory sourceFDA · substance-specific safety information↗Find researchPubMed · TB-500↗Research information, not a personal dosing plan. Last reviewed: 2026-11-01.